Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Cardiovasc Drugs. 2012 Feb 1;12(1):1-6. doi: 10.2165/11594580-000000000-00000.

Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?

Author information

  • 1Birmingham VA Medical Center, Birmingham, AL 35294, USA.

Abstract

Data supporting an association between high levels of serum urate and cardiovascular disease have continued to emerge. Basic science data, small clinical trials, and epidemiologic studies have provided support for the idea of a true causal effect. In this paper, we present evidence about the association between hyperuricemia and selected cardiovascular diseases. Although data generated so far compellingly support pharmacologic urate-lowering therapy in selected cases with high cardiovascular risk, further evidence is necessary before widely advocating this approach to prevent cardiovascular outcomes putatively associated with hyperuricemia.

PMID:
22204636
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk